Skip to content
Search

Latest Stories

£20 and £50 paper notes to expire by end of September

Businesses, including community pharmacies, that handle cash have been urged to prepare for the removal of £20 and £50 paper banknotes from circulation. The paper notes of both denominations will no longer be legal tender from Friday 30 September.

Cash handling experts Volumatic reminded businesses to make sure that they deposit any paper notes at banks by this date, and ensure they would not be accepting any further paper notes from customers from 1 October onwards.


“While businesses continue to face extra demands during the current cost-of living crisis, we’ve already seen evidence of an uplift in cash usage by consumers, who are now using cash more to help them budget more effectively,” Mike Severs, Sales and Marketing Director at Volumatic, said.

“With more consumers looking to spend their old paper notes before the end-of-September deadline, it’s really important to remember to deposit any paper notes you either already have within your business or receive throughout this month to your bank before the end of September.”

If retailers are unable to deposit paper notes at the bank, there is also the option of a postal exchange with the Bank of England or notes can be exchanged at selected Post Office branches.

Like the £5 and £10 notes before them, the paper £20 and £50 notes are being replaced by the new polymer banknotes, which were first issued in February 2020 and June 2021, respectively. And while these £20 and £50 polymer notes have replaced the majority of paper banknotes over the past couple of years, the Bank of England has estimated that there are still more than 14 billion paper £20 and £50 notes still in circulation.

The new notes are more durable, as they are made of plastic rather than paper, meaning fewer new notes will need to be issued over time. The notes are more state-of-the-art and therefore more secure, meaning they are far more difficult to forge.

Forged banknotes have caused headaches for retailers for many years, but since the £5 and £10 polymer notes were introduced in 2016-17, followed by the £20 and £50 notes more recently, completing the set, the UK has already seen a sharp decline in the number of counterfeit notes in circulation, Volumatic noted.

The Bank of England’s Banknote Statistics Data said that in 2021, typically less than 1 in every 40,000 banknotes were counterfeit in the UK, but that still equates to a face value of £2.7 million.

Volumatic said businesses can invest in its CounterCache intelligent (CCi) solution to help eliminate forgeries.

Currently used by businesses including Tesco, Morrisons, Wilko and the Co-op Food Group, CCi is an all-in-one unit that counts, detects 100% of forgeries and securely stores your cash, all at POS.

Notes cannot be touched or mislaid again until they reach the bank and the CCi also offers in-depth reporting for full visibility, and it can be integrated with any EPOS system or cash reconciliation software platform.

If a business has the need to count much larger volumes of cash, Volumatic’s Friction Note Counters can count banknotes quickly and accurately whilst at the same time detect all known forgeries.

The company added that both the CCi and its various friction note counter devices have passed the Bank of England’s framework test for banknote machines and forgery detectors, which means they will reject all known forgeries in circulation.

More For You

Pharmacies unable to dispense prescription due to supply shortages

Current legislation prevents pharmacists from making substitutions

Getty images

Medicine shortages: Pharmacies unable to dispense a prescription at least once a day

The National Pharmacy Association (NPA) has raised concerns over the growing crisis in medicine supply, warning that pharmacies are unable to dispense prescriptions at least once a day, posing a potential risk to patient health.

The organisation is calling on the government to reconsider allowing pharmacists to use their professional judgment to dispense a suitable alternative when the prescribed medication is unavailable.

Keep ReadingShow less
Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less